NRX Pharmaceuticals NRXP
NASDAQ NRXP
$2.90 +0.05 (+1.75%)
At close: Oct 2, 2026 · 4:00 PM EDT

NRX Pharmaceuticals (NRXP) Non Operating Investment Income (2017 - 2018)

Updated

NRX Pharmaceuticals (NRXP) reported Non Operating Investment Income of -$74.00 for Q4 2018.

Analysis

NRX Pharmaceuticals (NRXP) Non Operating Investment Income (2017 - 2018) Analysis & Trends

Dating back to Q1 2018, NRX Pharmaceuticals' Non Operating Investment Income record includes 4 quarters.

  • Five-year quarterly Non Operating Investment Income spans a low of -$4,740 in Q1 2018 and a high of $1,674 in Q3 2018.
  • Per Business Quant data, the three quarters before Q4 2018 came in at $1,674 (Q3 2018), -$1,599 (Q2 2018) and -$4,740 (Q1 2018).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 NRX Pharmaceuticals 125.16 Mn 76.75 Mn 426,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 -74.00
Jun 30, 2018 1,674.00
Mar 31, 2018 -1,599.00
Dec 31, 2017 -4,740.00
API Access

NRX Pharmaceuticals Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=NRXP&period=max&api_key=YOUR_API_KEY